The quinine market size has grown strongly in recent years. It will grow from $2.45 billion in 2025 to $2.68 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to traditional reliance on cinchona bark extraction, limited availability of purified quinine, widespread use in malaria treatment, use in home remedies and tonic beverages, adoption in oral formulations.
The quinine market size is expected to see strong growth in the next few years. It will grow to $3.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to technological advancements in quinine synthesis and purification, rising demand for pharmaceutical-grade quinine, expansion of malaria control programs, growth in functional beverages containing quinine, increased investment in antimalarial research and development. Major trends in the forecast period include rising demand for natural antimalarial compounds, increasing use of quinine in tonic beverages and functional drinks, development of pharmaceutical-grade quinine derivatives, growing awareness about malaria prevention and treatment, focus on regulatory compliance and quality standards for quinine products.
The increasing prevalence of malaria is anticipated to drive the growth of the quinine market in the coming years. Malaria is a parasitic infectious disease caused by Plasmodium species and transmitted to humans through the bites of infected female Anopheles mosquitoes. The incidence of malaria is rising due to increasing global temperatures, which are extending the geographical range and breeding periods of malaria-transmitting mosquitoes. Quinine is an effective antimalarial medication that supports malaria treatment by disrupting the parasite’s ability to metabolize hemoglobin within red blood cells, thereby inhibiting its growth and survival. For instance, in April 2024, according to the UK Health Security Agency, a UK-based government agency, there were 2,004 confirmed malaria cases reported in England in 2023, compared to 1,369 cases in 2022. Therefore, the rising prevalence of malaria is fueling the growth of the quinine market.
The expansion of the pharmaceutical industry is expected to further propel the growth of the quinine market going forward. The pharmaceutical industry encompasses the research, development, manufacturing, and commercialization of medicines aimed at preventing, treating, and managing diseases. The growth of the pharmaceutical industry is largely driven by an aging global population, which increases demand for treatments addressing age-related and chronic health conditions. Quinine supports the pharmaceutical sector by acting as a critical antimalarial active ingredient, maintaining treatment availability in regions affected by drug resistance while supporting continued formulation development, manufacturing activities, and global health initiatives. For instance, in November 2024, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Europe-based pharmaceutical industry body, pharmaceutical production in Europe increased from $393.3 billion (€363.3 billion) in 2022 to an estimated $422 billion (€390 billion) in 2023, representing year-over-year growth of around 7.3%. This increase reflects sustained investment in research and development, robust manufacturing capacity, and rising demand across multiple therapeutic segments. Therefore, the growth of the pharmaceutical industry is driving the expansion of the quinine market.
In June 2023, AlphaTalents Africa, an Africa-based investment company, acquired a controlling stake in Pharmakina for an undisclosed amount. Through this acquisition, AlphaTalents Africa aims to strengthen local quinine drug production, support regional communities, and promote sustainable growth within the Democratic Republic of the Congo. Pharmakina SA is an Africa-based pharmaceutical company engaged in the manufacturing of quinine.
Major companies operating in the quinine market are Teva Pharmaceutical Industries Ltd., Schweppes Australia Proprietary Limited, The United States Pharmacopeial Convention Inc., Chempro Pharma Private Limited, Taj Pharmaceuticals Ltd., Swiss Parenterals Private Limited, Leocorno Enterprises Private Limited, Healthy Inc., Jai Radhe Sales, Adooq Bioscience LLC, Akhil Healthcare Pvt Ltd., Van Wankum Ingredients B.V., Shreeji Pharma International, Prism Industries Private Limited, Lavina Pharmaceuticals Pvt Ltd., A. B. Enterprises, Spark Lifesciences Private Limited, Sihauli Chemicals Private Limited, Shanghai Nianxing Industrial Co. Ltd., Sakhiya Pharma Chem.
North America was the largest region in the quinine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quinine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the quinine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the quinine market by increasing the cost of imported raw materials and pharmaceutical intermediates, particularly affecting quinine sulfate and hydrochloride segments. Asia-Pacific regions such as India, Indonesia, and China, which are major producers of cinchona bark and quinine intermediates, face significant cost pressures. This has resulted in higher production costs and potential supply chain delays. On the positive side, tariffs encourage local extraction, processing initiatives, and investment in domestic manufacturing of quinine products.
The quinine market research report is one of a series of new reports that provides quinine market statistics, including quinine industry global market size, regional shares, competitors with a quinine market share, detailed quinine market segments, market trends and opportunities, and any further data you may need to thrive in the quinine industry. This quinine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Quinine is a naturally occurring compound obtained from the bark of the cinchona tree and has been traditionally used for the treatment of malaria. It acts by disrupting the growth and replication of the malaria parasite within red blood cells. In addition to its therapeutic use, quinine is also present in tonic water, where it provides a characteristic bitter flavor. Although effective, quinine is associated with certain side effects and has largely been replaced by newer antimalarial medications.
The main quinine products include quinine sulphate, quinine hydrochloride, quinine gluconate, and quinine bisulphate. Quinine sulphate, which is derived from the cinchona tree, is primarily used in malaria treatment and, in some cases, for nocturnal leg cramps. It can be administered through oral, intramuscular, intravenous, and other routes. Its applications include malaria management, treatment of nocturnal leg cramps, muscle pain, and restless leg syndrome, and it is used by end users such as hospitals, clinics, ambulatory surgical centers, and other healthcare facilities.
The quinine market consists of sales of products including topical ointments, bisulfate capsules, tonic water, and nutraceuticals. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The quinine market size is expected to see strong growth in the next few years. It will grow to $3.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to technological advancements in quinine synthesis and purification, rising demand for pharmaceutical-grade quinine, expansion of malaria control programs, growth in functional beverages containing quinine, increased investment in antimalarial research and development. Major trends in the forecast period include rising demand for natural antimalarial compounds, increasing use of quinine in tonic beverages and functional drinks, development of pharmaceutical-grade quinine derivatives, growing awareness about malaria prevention and treatment, focus on regulatory compliance and quality standards for quinine products.
The increasing prevalence of malaria is anticipated to drive the growth of the quinine market in the coming years. Malaria is a parasitic infectious disease caused by Plasmodium species and transmitted to humans through the bites of infected female Anopheles mosquitoes. The incidence of malaria is rising due to increasing global temperatures, which are extending the geographical range and breeding periods of malaria-transmitting mosquitoes. Quinine is an effective antimalarial medication that supports malaria treatment by disrupting the parasite’s ability to metabolize hemoglobin within red blood cells, thereby inhibiting its growth and survival. For instance, in April 2024, according to the UK Health Security Agency, a UK-based government agency, there were 2,004 confirmed malaria cases reported in England in 2023, compared to 1,369 cases in 2022. Therefore, the rising prevalence of malaria is fueling the growth of the quinine market.
The expansion of the pharmaceutical industry is expected to further propel the growth of the quinine market going forward. The pharmaceutical industry encompasses the research, development, manufacturing, and commercialization of medicines aimed at preventing, treating, and managing diseases. The growth of the pharmaceutical industry is largely driven by an aging global population, which increases demand for treatments addressing age-related and chronic health conditions. Quinine supports the pharmaceutical sector by acting as a critical antimalarial active ingredient, maintaining treatment availability in regions affected by drug resistance while supporting continued formulation development, manufacturing activities, and global health initiatives. For instance, in November 2024, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Europe-based pharmaceutical industry body, pharmaceutical production in Europe increased from $393.3 billion (€363.3 billion) in 2022 to an estimated $422 billion (€390 billion) in 2023, representing year-over-year growth of around 7.3%. This increase reflects sustained investment in research and development, robust manufacturing capacity, and rising demand across multiple therapeutic segments. Therefore, the growth of the pharmaceutical industry is driving the expansion of the quinine market.
In June 2023, AlphaTalents Africa, an Africa-based investment company, acquired a controlling stake in Pharmakina for an undisclosed amount. Through this acquisition, AlphaTalents Africa aims to strengthen local quinine drug production, support regional communities, and promote sustainable growth within the Democratic Republic of the Congo. Pharmakina SA is an Africa-based pharmaceutical company engaged in the manufacturing of quinine.
Major companies operating in the quinine market are Teva Pharmaceutical Industries Ltd., Schweppes Australia Proprietary Limited, The United States Pharmacopeial Convention Inc., Chempro Pharma Private Limited, Taj Pharmaceuticals Ltd., Swiss Parenterals Private Limited, Leocorno Enterprises Private Limited, Healthy Inc., Jai Radhe Sales, Adooq Bioscience LLC, Akhil Healthcare Pvt Ltd., Van Wankum Ingredients B.V., Shreeji Pharma International, Prism Industries Private Limited, Lavina Pharmaceuticals Pvt Ltd., A. B. Enterprises, Spark Lifesciences Private Limited, Sihauli Chemicals Private Limited, Shanghai Nianxing Industrial Co. Ltd., Sakhiya Pharma Chem.
North America was the largest region in the quinine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quinine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the quinine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the quinine market by increasing the cost of imported raw materials and pharmaceutical intermediates, particularly affecting quinine sulfate and hydrochloride segments. Asia-Pacific regions such as India, Indonesia, and China, which are major producers of cinchona bark and quinine intermediates, face significant cost pressures. This has resulted in higher production costs and potential supply chain delays. On the positive side, tariffs encourage local extraction, processing initiatives, and investment in domestic manufacturing of quinine products.
The quinine market research report is one of a series of new reports that provides quinine market statistics, including quinine industry global market size, regional shares, competitors with a quinine market share, detailed quinine market segments, market trends and opportunities, and any further data you may need to thrive in the quinine industry. This quinine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Quinine is a naturally occurring compound obtained from the bark of the cinchona tree and has been traditionally used for the treatment of malaria. It acts by disrupting the growth and replication of the malaria parasite within red blood cells. In addition to its therapeutic use, quinine is also present in tonic water, where it provides a characteristic bitter flavor. Although effective, quinine is associated with certain side effects and has largely been replaced by newer antimalarial medications.
The main quinine products include quinine sulphate, quinine hydrochloride, quinine gluconate, and quinine bisulphate. Quinine sulphate, which is derived from the cinchona tree, is primarily used in malaria treatment and, in some cases, for nocturnal leg cramps. It can be administered through oral, intramuscular, intravenous, and other routes. Its applications include malaria management, treatment of nocturnal leg cramps, muscle pain, and restless leg syndrome, and it is used by end users such as hospitals, clinics, ambulatory surgical centers, and other healthcare facilities.
The quinine market consists of sales of products including topical ointments, bisulfate capsules, tonic water, and nutraceuticals. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Quinine Market Characteristics
3. Quinine Market Supply Chain Analysis
4. Global Quinine Market Trends and Strategies
5. Quinine Market Analysis of End Use Industries
7. Global Quinine Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Quinine Total Addressable Market (TAM) Analysis for the Market
9. Quinine Market Segmentation
10. Quinine Market Regional and Country Analysis
11. Asia-Pacific Quinine Market
12. China Quinine Market
13. India Quinine Market
14. Japan Quinine Market
15. Australia Quinine Market
16. Indonesia Quinine Market
17. South Korea Quinine Market
18. Taiwan Quinine Market
19. South East Asia Quinine Market
20. Western Europe Quinine Market
21. UK Quinine Market
22. Germany Quinine Market
23. France Quinine Market
24. Italy Quinine Market
25. Spain Quinine Market
26. Eastern Europe Quinine Market
27. Russia Quinine Market
28. North America Quinine Market
29. USA Quinine Market
30. Canada Quinine Market
31. South America Quinine Market
32. Brazil Quinine Market
33. Middle East Quinine Market
34. Africa Quinine Market
36. Quinine Market Competitive Landscape and Company Profiles
37. Quinine Market Other Major and Innovative Companies
40. Quinine Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Quinine Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses quinine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for quinine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quinine market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Quinine Sulphate; Quinine Hydrochloride; Quinine Gluconate; Quinine Bisulphate2) By Administration: Oral Administration; Intramuscular Administration; Intravenous Administration; Other Administrations
3) By Application: Malaria Treatment; Nocturnal Leg Cramps
4) By Enduser: Hospitals; Clinics; Other Endusers
Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Schweppes Australia Proprietary Limited; The United States Pharmacopeial Convention Inc.; Chempro Pharma Private Limited; Taj Pharmaceuticals Ltd.; Swiss Parenterals Private Limited; Leocorno Enterprises Private Limited; Healthy Inc.; Jai Radhe Sales; Adooq Bioscience LLC; Akhil Healthcare Pvt Ltd.; Van Wankum Ingredients B.V.; Shreeji Pharma International; Prism Industries Private Limited; Lavina Pharmaceuticals Pvt Ltd.; A. B. Enterprises; Spark Lifesciences Private Limited; Sihauli Chemicals Private Limited; Shanghai Nianxing Industrial Co. Ltd.; Sakhiya Pharma Chem
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Quinine market report include:- Teva Pharmaceutical Industries Ltd.
- Schweppes Australia Proprietary Limited
- The United States Pharmacopeial Convention Inc.
- Chempro Pharma Private Limited
- Taj Pharmaceuticals Ltd.
- Swiss Parenterals Private Limited
- Leocorno Enterprises Private Limited
- Healthy Inc.
- Jai Radhe Sales
- Adooq Bioscience LLC
- Akhil Healthcare Pvt Ltd.
- Van Wankum Ingredients B.V.
- Shreeji Pharma International
- Prism Industries Private Limited
- Lavina Pharmaceuticals Pvt Ltd.
- A. B. Enterprises
- Spark Lifesciences Private Limited
- Sihauli Chemicals Private Limited
- Shanghai Nianxing Industrial Co. Ltd.
- Sakhiya Pharma Chem
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.68 Billion |
| Forecasted Market Value ( USD | $ 3.76 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
